October 18, 2017 4:44 AM ET

Pharmaceuticals

Company Overview of Zdravlje A.D.

Company Overview

Zdravlje A.D. manufactures pharmaceuticals. The company is based in Leskovac, Serbia. Zdravlje A.D. operates as a subsidiary of Allergan plc.

Vlajkova 199

Leskovac,  16000

Serbia

Phone:

381 16 202 000

Fax:

381 16 250 511

Key Executives for Zdravlje A.D.

Managing Director
Financial Director
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
FARMAKOS Europe
Galenika a.d. Europe
Joint stock company for medical goods supply MEDIFARM Europe
Kondirolli Europe
Pharmanova d.o.o Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Zdravlje A.D., please visit www.actavis.rs/sr/AboutUs/Contact/Zdravlje+Actavis.htm. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.